Literature DB >> 19370764

Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma.

Emanuele Persichetti1, Nadia A Chuzhanova, Andrea Dardis, Barbara Tappino, Sandra Pohl, Nick S T Thomas, Camillo Rosano, Chiara Balducci, Silvia Paciotti, Silvia Dominissini, Anna Lisa Montalvo, Michela Sibilio, Rossella Parini, Miriam Rigoldi, Maja Di Rocco, Giancarlo Parenti, Aldo Orlacchio, Bruno Bembi, David N Cooper, Mirella Filocamo, Tommaso Beccari.   

Abstract

Mucolipidosis type III (MLIII) is an autosomal recessive disorder affecting lysosomal hydrolase trafficking. In a study of 10 patients from seven families with a clinical phenotype and enzymatic diagnosis of MLIII, six novel GNPTG gene mutations were identified. These included missense (p.T286M) and nonsense (p.W111X) mutations and a transition in the obligate AG-dinucleotide of the intron 8 acceptor splice site (c.610-2A>G). Three microdeletions were also identified, two of which (c.611delG and c.640_667del28) were located within the coding region whereas one (c.609+28_610-16del) was located entirely within intron 8. RT-PCR analysis of the c.610-2A>G transition demonstrated that the change altered splicing, leading to the production of two distinct aberrantly spliced forms, viz. the skipping of exon 9 (p.G204_K247del) or the retention of introns 8 and 9 (p.G204VfsX28). RT-PCR analysis, performed on a patient homozygous for the intronic deletion (c.609+28_610-16del), failed to detect any GNPTG RNA transcripts. To determine whether c.609+28_610-16del allele-derived transcripts were subject to nonsense-mediated mRNA decay (NMD), patient fibroblasts were incubated with the protein synthesis inhibitor anisomycin. An RT-PCR fragment retaining 43 bp of intron 8 was consistently detected suggesting that the 33-bp genomic deletion had elicited NMD. Quantitative real-time PCR and GNPTG western blot analysis confirmed that the homozygous microdeletion p.G204VfsX17 had elicited NMD resulting in failure to synthesize GNPTG protein. Analysis of the sequences surrounding the microdeletion breakpoints revealed either intrinsic repetitivity of the deleted region or short direct repeats adjacent to the breakpoint junctions. This is consistent with these repeats having mediated the microdeletions via replication slippage and supports the view that the mutational spectrum of the GNPTG gene is strongly influenced by the properties of the local DNA sequence environment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370764     DOI: 10.1002/humu.20959

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  Enzyme-specific differences in mannose phosphorylation between GlcNAc-1-phosphotransferase αβ and γ subunit deficient zebrafish support cathepsin proteases as early mediators of mucolipidosis pathology.

Authors:  Heather Flanagan-Steet; Courtney Matheny; Aaron Petrey; Joshua Parker; Richard Steet
Journal:  Biochim Biophys Acta       Date:  2016-05-27

2.  Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.

Authors:  Yu Wang; Jun Ye; Wen-Juan Qiu; Lian-Shu Han; Xiao-Lan Gao; Li-Li Liang; Xue-Fan Gu; Hui-Wen Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-06-05       Impact factor: 6.150

3.  Enigmatic in vivo GlcNAc-1-phosphotransferase (GNPTG) transcript correction to wild type in two mucolipidosis III gamma siblings homozygous for nonsense mutations.

Authors:  Renata Voltolini Velho; Nataniel Floriano Ludwig; Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Ursula Matte; Ida V D Schwartz
Journal:  J Hum Genet       Date:  2016-03-03       Impact factor: 3.172

4.  Mucolipidosis III GNPTG Missense Mutations Cause Misfolding of the γ Subunit of GlcNAc-1-Phosphotransferase.

Authors:  Eline van Meel; Stuart Kornfeld
Journal:  Hum Mutat       Date:  2016-04-22       Impact factor: 4.878

5.  Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Authors:  Giorgia Di Lorenzo; Renata Voltolini Velho; Dominic Winter; Melanie Thelen; Shiva Ahmadi; Michaela Schweizer; Raffaella De Pace; Kerstin Cornils; Timur Alexander Yorgan; Saskia Grüb; Irm Hermans-Borgmeyer; Thorsten Schinke; Sven Müller-Loennies; Thomas Braulke; Sandra Pohl
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

6.  A contracted DNA repeat in LHX3 intron 5 is associated with aberrant splicing and pituitary dwarfism in German shepherd dogs.

Authors:  Annemarie M W Y Voorbij; Frank G van Steenbeek; Manon Vos-Loohuis; Ellen E C P Martens; Jeanette M Hanson-Nilsson; Bernard A van Oost; Hans S Kooistra; Peter A Leegwater
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

7.  Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site.

Authors:  Renata Voltolini Velho; Raffaella De Pace; Sarah Klünder; Fernanda Sperb-Ludwig; Charles Marques Lourenço; Ida V D Schwartz; Thomas Braulke; Sandra Pohl
Journal:  Hum Mol Genet       Date:  2015-03-18       Impact factor: 6.150

8.  Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.

Authors:  Rachel A Idol; David F Wozniak; Hideji Fujiwara; Carla M Yuede; Daniel S Ory; Stuart Kornfeld; Peter Vogel
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling.

Authors:  Renata Voltolini Velho; Taciane Alegra; Fernanda Sperb; Nataniel Floriano Ludwig; Maria Luiza Saraiva-Pereira; Ursula Matte; Ida V D Schwartz
Journal:  Mol Genet Metab Rep       Date:  2014-02-27

10.  Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease.

Authors:  Ville-Petteri Mäkinen; Mete Civelek; Qingying Meng; Bin Zhang; Jun Zhu; Candace Levian; Tianxiao Huan; Ayellet V Segrè; Sujoy Ghosh; Juan Vivar; Majid Nikpay; Alexandre F R Stewart; Christopher P Nelson; Christina Willenborg; Jeanette Erdmann; Stefan Blakenberg; Christopher J O'Donnell; Winfried März; Reijo Laaksonen; Stephen E Epstein; Sekar Kathiresan; Svati H Shah; Stanley L Hazen; Muredach P Reilly; Aldons J Lusis; Nilesh J Samani; Heribert Schunkert; Thomas Quertermous; Ruth McPherson; Xia Yang; Themistocles L Assimes
Journal:  PLoS Genet       Date:  2014-07-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.